Advertisement Oragenics to introduce oral probiotics in Australia, New Zealand - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Oragenics to introduce oral probiotics in Australia, New Zealand

Oragenics is set to make oral care probiotics ProBiora3, EvoraPlus and EvoraKids available in Australia and New Zealand, following an agreement signed with Australian Pharmaceutical Industries (API).

ProBiora3 supports gum and tooth health while freshening breath and whitening teeth and can be used by children and adults both, while EvoraPlus is a probiotic mint for adults that supports gum and tooth health, freshens breath gently and naturally whitens teeth.

The tie up will allow Oragenics to enter into Australian and New Zealand markets and is expected to accelerate the registration process of the company’s oral care probiotics in these countries.

Oragenics Sales and Marketing executive vice president Gerry David said API’s experience in handling probiotics, coupled with their retail presence, will greatly benefit the launch of EvoraPlus and EvoraKids in these countries.